The COVID-19 public health emergency will be extended for another three months, which means it will continue through the midterm elections. The Department of Health and Human Services had already extended it through October 13 and said it would provide 60 days of notice before halting it. (Axios)

Merck and Orna Therapeutics, a Massachusetts-based startup, have agreed to collaborate on the development of mRNA vaccines. Merck will pay Orna $150 million upfront and up to $3.5 billion in milestones. (STAT)

The Food and Drug Administration has given priority review to the AstraZeneca/Merck Lynparza combo therapy for metastatic prostate cancer. The drug is currently approved for metastatic castration-resistant prostate cancer with certain gene mutations. (Endpoints News)

RIP Medical Debt, a nonprofit founded to help pay off patients’ medical debts, has erased $6.7 billion in debt. Recent donations, including $50 million from philanthropist MacKenzie Scott, has helped the nonprofit expand its mission. (Kaiser Health News)

Impact from the Zika virus is still felt in Brazil, where babies born during the 2015-2016 viral outbreak are now children. Families continue to face hearing and visual problems, cognitive difficulties and other medical problems. (The New York Times)